1. Home
  2. AYTU vs CLWT Comparison

AYTU vs CLWT Comparison

Compare AYTU & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • CLWT
  • Stock Information
  • Founded
  • AYTU N/A
  • CLWT 1971
  • Country
  • AYTU United States
  • CLWT Hong Kong
  • Employees
  • AYTU N/A
  • CLWT N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • CLWT Professional and commerical equipment
  • Sector
  • AYTU Health Care
  • CLWT Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • CLWT Nasdaq
  • Market Cap
  • AYTU 15.0M
  • CLWT 12.8M
  • IPO Year
  • AYTU N/A
  • CLWT 1997
  • Fundamental
  • Price
  • AYTU $2.21
  • CLWT $1.62
  • Analyst Decision
  • AYTU
  • CLWT
  • Analyst Count
  • AYTU 0
  • CLWT 0
  • Target Price
  • AYTU N/A
  • CLWT N/A
  • AVG Volume (30 Days)
  • AYTU 30.7K
  • CLWT 6.6K
  • Earning Date
  • AYTU 11-12-2024
  • CLWT 04-30-2024
  • Dividend Yield
  • AYTU N/A
  • CLWT 5.13%
  • EPS Growth
  • AYTU N/A
  • CLWT 395.79
  • EPS
  • AYTU N/A
  • CLWT 0.24
  • Revenue
  • AYTU $81,002,000.00
  • CLWT $17,940,000.00
  • Revenue This Year
  • AYTU N/A
  • CLWT N/A
  • Revenue Next Year
  • AYTU N/A
  • CLWT N/A
  • P/E Ratio
  • AYTU N/A
  • CLWT $7.02
  • Revenue Growth
  • AYTU N/A
  • CLWT 20.01
  • 52 Week Low
  • AYTU $2.20
  • CLWT $1.22
  • 52 Week High
  • AYTU $3.50
  • CLWT $1.94
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 44.06
  • CLWT 49.39
  • Support Level
  • AYTU $2.25
  • CLWT $1.49
  • Resistance Level
  • AYTU $2.44
  • CLWT $1.66
  • Average True Range (ATR)
  • AYTU 0.13
  • CLWT 0.08
  • MACD
  • AYTU -0.01
  • CLWT -0.01
  • Stochastic Oscillator
  • AYTU 14.17
  • CLWT 60.00

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

Share on Social Networks: